Renal Anemia Clinical Trial
Official title:
Long-term Special Drug Use Investigation of Molidustat for Patients With Renal Anemia
In this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and women who have renal anemia, a condition in which the kidneys do not make enough of a hormone that helps the body make new red blood cells. In previous clinical trials with a small number of participants, several important adverse events were observed. The researchers in this study want to know how many patients also have these adverse events under the real world, and if the number of the red blood cells will be increased after the treatment of Molidustat. The researchers will collect the participants' health information from their medical records and their regular check-ups for up to 2 years. The data from this study will be submitted to the health authority in Japan in accordance with the local regulation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04925661 -
HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
|
Phase 1 | |
| Active, not recruiting |
NCT03388385 -
Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD
|
Phase 4 | |
| Completed |
NCT05035641 -
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
|
Phase 2 | |
| Completed |
NCT02299661 -
Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
|
Phase 1 | |
| Active, not recruiting |
NCT05265325 -
A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
|
Phase 2 | |
| Completed |
NCT05864261 -
Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers
|
Phase 4 | |
| Active, not recruiting |
NCT05085275 -
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
|
Phase 3 | |
| Completed |
NCT02708914 -
Study to Compare the Safety and Efficacy of UB-851 and Eprex®
|
Phase 3 | |
| Completed |
NCT02041208 -
Variability of Hemoglobin Levels After Kidney Transplantation
|
N/A | |
| Not yet recruiting |
NCT04775615 -
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.
|
Phase 1 | |
| Completed |
NCT00298441 -
Efficacy of Intravenous Iron Administration in Hemodialysis Patients
|
Phase 4 | |
| Active, not recruiting |
NCT04408820 -
Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
|
||
| Completed |
NCT01543477 -
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
|
||
| Completed |
NCT05951192 -
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
|
Phase 4 | |
| Completed |
NCT04454879 -
Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients
|
Phase 4 | |
| Recruiting |
NCT04360902 -
Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients
|
N/A | |
| Not yet recruiting |
NCT03480178 -
Renal Anemia Refractory to Erythropoietin
|
||
| Completed |
NCT01306409 -
Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
|
Phase 4 | |
| Completed |
NCT00322413 -
Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
|
Phase 3 | |
| Recruiting |
NCT05970172 -
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
|
Phase 3 |